-
Clinicians who opt to use azithromycin for treatment of early syphilis should review recently published research that indicates that at least 10% of syphilis samples from patients at sexually transmitted disease (STD) clinics in four cities had a strain resistant to the antibiotic.
-
Checking your next patients chart, you see that the young woman uses depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City) for birth control. When you ask about her last injection, she tells you she missed her scheduled shot because she was out of town.
-
If your practice includes care of lesbian and bisexual women, and most practices do, dont dismiss taking their reproductive histories. New research indicates that previous pregnancy, induced abortion, and hormonal contraceptive use are common among women who report sex with women, regardless of whether they identify themselves as lesbian.
-
Want to see more adolescents at your facility? Planned Parenthood of South Palm Beach and Broward County (PPSPBBC) in Boca Raton, FL, has captured teens attention by packaging a comprehensive health screening with a years supply of free birth control pills.
-
Where does your state stand when it comes to funding for abstinence-only programs? A new report released by the New York City-based Sexuality Information and Education Council of the U.S. (SIECUS) details the amount, type, and use of federal abstinence-only-until-marriage funds in all 50 states and the District of Columbia.
-
-
The National Cholesterol Education Program, a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.
-
12-lead ECG obtained from a healthy, asymptomatic 42-year-old man. How many findings can you identify?
-
Angiotensin-converting enzyme inhibitors decreased the number of defibrillation attempts needed and reduced hospitalization in patients with atrial fibrillation.
-
In patients with symptomatic nonerosive reflux disease, intermittent on-demand therapy with the PPI rabeprazole provided good symptom control with tablets taken on average approximately 1 day out of 4.